Colour Doppler Flow Imaging in Lacrimal Gland Lesions

Retrospective medical charts and medical imaging files review of patients suffering from lacrimal fossa lesions who underwent ocular ultrasonography with color flow doppler imaging.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lacrimal Tumor

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients suffering from lacrimal fossa tumor
Orbital ultrasonography performed, including doppler flow imaging
Histopathological characterization of the tumor obtained after surgical removal

Exclusion criteria

Absence of histopathological characterization
Absence of documented ultrasound doppler flow imaging

Treatment and study plan

Primary outcomes

Pulsed wave doppler resistance index in tumor vascularization

Time frame: 1 week

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Official study title

Usefulness of Colour Doppler Flow Imaging in the Management of Lacrimal Gland Lesions

Acronym: GLIR

Important dates

Study start: 2003
Primary completion: 2015
Study completion: 2016
First posted: Sep 14, 2016
Registry last updated: Jan 31, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.